Table 2.
Criterion | Top-down reimbursement pathway | Bottom-up reimbursement pathway |
---|---|---|
Coverage | ● National/large population | ● Local/regional/payer-specific population |
Evidence | ● Usually randomized controlled trials (RCTs) | ● Any type, particularly real-world data (RWD) |
Timeframe | ● Long | ● Moderate |